Development of C21 in IPF on track; final Phase 2a AIR data in first half of 2024 and Phase 2b ASPIRE initiation in first half of 2024 AlmeeTM pivotal study COMPANION completion on-track; topline results expected to be announced this month Transition to late-stage development of C21 in IPF drives increased focus in pipeline; preclinical […]